AGENUS INC(AGEN)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

AGENUS INC (AGEN) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores AGEN at 53.3/100 on a 32-signal composite quality model, placing it at rank #1,397 of 2,961 stocks — the top half of the AI-ranked universe. AGEN scores in the top quartile across balance sheet strength (99.5), profitability (99.0), institutional flow (83.1). Areas of concern include free cash flow (7.5) and earnings quality (8.3), which score below median versus the broader universe. Shareholder dilution risk is elevated at 14.3/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), AGENUS INC reports quarterly revenue of $34.5M, net income of $-567.0K, free cash flow of $-31.2M. AGEN trades on the Nasdaq exchange and files with the SEC under CIK 1098972. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate AGEN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for AGENUS INC directly from SEC EDGAR.